These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8099452)

  • 1. The prognostic significance of proliferating cell nuclear antigen in clinical gastric cancer.
    Mori M; Kakeji Y; Adachi Y; Moriguchi S; Maehara Y; Sugimachi K; Jessup JM; Chen LB; Steele GD
    Surgery; 1993 Jun; 113(6):683-90. PubMed ID: 8099452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of proliferative activity using anti-proliferating cell nuclear antigen antibody in gastric cancer tissue specimens obtained by endoscopic biopsy.
    Yonemura Y; Kimura H; Fushida S; Tugawa K; Nakai Y; Kaji M; Fonseca L; Yamaguchi A; Miyazaki I
    Cancer; 1993 Apr; 71(8):2448-53. PubMed ID: 8095851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferating cell nuclear antigen labeling index of preoperative biopsy specimens in gastric carcinoma with special reference to prognosis.
    Maeda K; Chung YS; Onoda N; Kato Y; Nitta A; Arimoto Y; Yamada N; Kondo Y; Sowa M
    Cancer; 1994 Feb; 73(3):528-33. PubMed ID: 7905361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical detection of p53 protein, c-erbB-2 protein, epidermal growth factor receptor protein and proliferating cell nuclear antigen in gastric carcinoma.
    Jang WI; Yang WI; Lee CI; Kim HS; Song KS; Cho MY; Park JK; Shim YH
    J Korean Med Sci; 1993 Aug; 8(4):293-304. PubMed ID: 7911025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of lymph node metastasis and prognosis from the assay of the expression of proliferating cell nuclear antigen and DNA ploidy in gastric cancer.
    Yonemura Y; Fonseca L; Tsugawa K; Ninomiya I; Matsumoto H; Sugiyama K; Ohoyama S; Fushida S; Kimura H; Miyazaki I
    Oncology; 1994; 51(3):251-7. PubMed ID: 7910957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferating cell nuclear antigen immunohistochemistry using monoclonal antibody 19A2 and a new antigen retrieval technique has prognostic impact in archival paraffin-embedded node-negative breast cancer.
    Siitonen SM; Kallioniemi OP; Isola JJ
    Am J Pathol; 1993 Apr; 142(4):1081-9. PubMed ID: 7682759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleolar organizer regions (NORs) staining and proliferating cell nuclear antigen (PCNA) immunostaining in mucosa-associated lymphoid tissue (MALT) gastric lymphomas.
    Mikou P; Kanavaros P; Aninos D; Tzardi M; Karameris A; Gorgoulis B; Papadopoulos N; Lavergne A; Galian A
    Pathol Res Pract; 1993 Nov; 189(9):1004-9. PubMed ID: 7905623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliferative activity of gastric cancer assessed by immunostaining for proliferating cell nuclear antigen.
    Inada T; Imura J; Ichikawa A; Ogata Y; Shimamura K
    J Surg Oncol; 1993 Nov; 54(3):146-51; discussion 151-2. PubMed ID: 8105151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of proliferating cell nuclear antigen (PCNA) expression in gastric cancer in relation to lymph node metastasis.
    Isozaki H; Okajima K; Ichinona T; Fujii K; Nomura E; Izumi N; Takeda Y
    J Surg Oncol; 1996 Feb; 61(2):106-10. PubMed ID: 8606541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microvessel count, proliferating cell nuclear antigen and Ki-67 indices in gastric adenocarcinoma.
    Elpek GO; Gelen T; Aksoy NH; Karpuzoglu T; Keles N
    Pathol Oncol Res; 2000; 6(1):59-64. PubMed ID: 10749590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of p53 expression and proliferative activity in gastric cancer.
    Yonemura Y; Fushida S; Tsugawa K; Ninomiya I; Fonseca L; Yamaguchi A; Miyazaki I; Urano T; Shiku H
    Anal Cell Pathol; 1993 Sep; 5(5):277-88. PubMed ID: 8105878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of proliferating cell nuclear antigen in gastric carcinoma.
    Jain S; Filipe MI; Hall PA; Waseem N; Lane DP; Levison DA
    J Clin Pathol; 1991 Aug; 44(8):655-9. PubMed ID: 1679766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation of proliferating cell nuclear antigen (PCNA) labeling rate and malignancy in gastric cancer: preliminary report].
    Yonemura Y; Yamaguchi A; Kaji M; Fushida S; Tugawa K; Fonseca L; Miyazaki I
    Nihon Geka Gakkai Zasshi; 1992 Jun; 93(6):661. PubMed ID: 1352850
    [No Abstract]   [Full Text] [Related]  

  • 14. The expression of proliferating cell nuclear antigen in hepatocellular carcinoma.
    Wu JD; Tseng HH
    Zhonghua Yi Xue Za Zhi (Taipei); 1994 Apr; 53(4):198-203. PubMed ID: 7911731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferating cell nuclear antigen immunostaining in breast cancer and its relation to prognosis.
    Narita T; Funahashi H; Satoh Y; Takagi H
    Jpn J Clin Oncol; 1993 Feb; 23(1):20-5. PubMed ID: 8096256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic significance of proliferating cell nuclear antigen in patients with lymph node-positive breast cancer.
    Sheen-Chen SM; Eng HL; Chou FF; Chen WJ
    Arch Surg; 1997 Mar; 132(3):264-7. PubMed ID: 9125025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of early relapse and shortened survival in patients with breast cancer by proliferating cell nuclear antigen score.
    Tahan SR; Neuberg DS; Dieffenbach A; Yacoub L
    Cancer; 1993 Jun; 71(11):3552-9. PubMed ID: 8098267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Contribution of proliferating cell nuclear antigen to prognostic evaluation of carcinomas of the maxillary sinus].
    Mikuni H; Fukuda S; Furuta Y; Takasu T; Nagahashi T; Inuyama Y
    Nihon Jibiinkoka Gakkai Kaiho; 1992 Dec; 95(12):1944-9. PubMed ID: 1362772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of expression of proliferating cell nuclear antigen and E-cadherin in gastric carcinoma.
    Hu L; Li HL; Li WF; Chen JM; Yang JT; Gu JJ; Xin L
    World J Gastroenterol; 2017 May; 23(20):3721-3729. PubMed ID: 28611525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poor prognostic value of proliferating cell nuclear antigen labelling index in breast carcinoma.
    Thomas M; Noguchi M; Kitagawa H; Kinoshita K; Miyazaki I
    J Clin Pathol; 1993 Jun; 46(6):525-8. PubMed ID: 8101192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.